Search

Your search keyword '"Cobo, S."' showing total 168 results

Search Constraints

Start Over You searched for: Author "Cobo, S." Remove constraint Author: "Cobo, S." Language english Remove constraint Language: english
168 results on '"Cobo, S."'

Search Results

1. TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy

2. Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer

4. 237MO TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy without immunotherapy

6. 126MO HER2DX and pathological complete response in HER2-positive breast cancer: A combined analysis of 4 neoadjuvant studies

7. 234P Real-world treatment patterns and outcomes of patients receiving palbociclib plus endocrine therapy in Spain: Subgroup analysis based on age, sites and number of metastatic locations, menopausal status and dose received from PALBOSPAIN study

8. 218P Characteristics and outcomes of HER2-low (H-Low) and HER2-zero (H-0) advanced breast cancer (ABC) patients (pts) from GEICAM/2014-03 (RegistEM) registry

9. 114P Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies

11. 216P Relationship between regulatory T lymphocytes (Treg): Related genes and pathological response to neoadjuvant docetaxel-carboplatin in early-stage triple-negative breast cancer (TNBC)

12. 281P Prevalence of HER2-low breast cancer in the GEICAM/2011-06 trial: Agreement in HER2-low classification between standardized immunohistochemistry assays

13. 261P Subtyping of residual disease (RD) following neoadjuvant chemotherapy (NACT) for triple negative breast cancer (TNBC): Evolution and prognostic impact

14. 258P Correlation between pathological complete response (pCR) following neoadjuvant docetaxel, carboplatin and trastuzumab (TCH) with or without pertuzumab (TCHP) and PAM50 subtypes in HER2(+) early breast cancer (eBC)

15. P2.16-02 Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-Stage Small Cell Lung Cancer: PEERS Phase 2 Trial

16. 233P Germline genetic testing before formal counseling: Impact in cancer management in a Spanish university hospital

17. 406P Phase Ib safety and efficacy of nadunolimab/gemcitabine/carboplatin in mTNBC

18. 356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study

19. 141MO Pathological response and early survival data according to TNBCtype4 classifier in operable triple-negative breast cancer (TNBC) treated with neoadjuvant carboplatin and docetaxel

20. 85P Correlation between nCOUNTER PAM-50 assay and three IHC-based surrogate intrinsic breast cancer subtype classifiers: A real-world study

21. 62P Outcomes of high-risk breast cancer (BC) patients from El Álamo IV registry and GEICAM adjuvant clinical trials

22. TDS study of deuterium distribution in 3$^{rd}$ generation high strength steels as a function of charging conditions and cold rolling

23. Hydrogen distribution in 3rd generation high strength steels and its effect on mechanical properties

24. Hydrogen distribution in a MnAl high strength steel and its effect on mechanical properties

26. Deformation substructure of austenite evaluated by crystallographic reconstruction and its influence on microstructure inheritance in low carbon steels

27. Variación patogénica y fuentes de resistencia a Colletotrichum lindemuthianum Sacc & magn Scrib., patógeno de la antracnosis del frijol, en Colombia Variación patogénica y fuentes de resistencia a Colletotrichum lindemuthianum (Sacc & Magn) Scrib., patógeno de la antracnosis del fríjol, en Colombia

28. 942 - The chemokine IP10 (CXCL10) dominates the long-term immune response stimulated by BCG treatment of non-muscle invasive bladder cancer, but a high concentration of IP10 in urine is strongly indicative of risk for the development of intolerance to BCG

31. LBA20 - Safety and immunobiological activity of intratumoral (IT) double-stranded RNA (dsRNA) BO-112 in solid malignancies: First in human clinical trial

33. 186P - Breast cancer PAM50 subtypes: Correlation between RNA-Seq and multiplexed gene expression platforms

34. Electrochemical control of the switching process of photochromic dimethyldihydropyrene derivatives.

35. Self-assembled dimethyldihydropyrene-pyridyl substituted ligands with zinc(ii) meso-tetraphenylporphyrin via axial coordination.

37. Heart Rate Variability: a Follow-up in Elite Soccer Players Throughout the Season.

38. Effects of Eccentric Overload Bout on Change of Direction and Performance in Soccer Players.

41. Interstitial pneumonitis and lung fibrosis during adjuvant treatment of melanoma with interferon alpha according to the Kirkwood schedule.

47. Mapping the Extended Ground State Reactivity Landscape of a Photoswitchable Molecule at a Single Molecular Level.

48. Electron-Transfer-Induced Structural Modification in a Thermochromic Hofmann Clathrate Derivative.

49. Ablation of FAS confers allogeneic CD3 - CAR T cells with resistance to rejection by T cells and natural killer cells.

50. Hofmann Clathrates: A "Blue Box" Approach to Modulate Spin-Crossover Properties.

Catalog

Books, media, physical & digital resources